Company Profiles

driven by the PitchBook Platform

Avexxin

Description

Developer of therapeutics for patients with chronic inflammatory conditions. The company is a pharmaceutical enterprise focused on developing and commercializing novel, small-molecule therapeutics for the treatment of psoriasis and other inflammatory disorders.

2005

Founded

PRIVATE

Status

Series B

Latest Deal Type

$1.8M

Latest Deal Amount

$7.06M

Total Amount Raised

4

Investors

Description

Developer of therapeutics for patients with chronic inflammatory conditions. The company is a pharmaceutical enterprise focused on developing and commercializing novel, small-molecule therapeutics for the treatment of psoriasis and other inflammatory disorders.

Website:

www.avexxin.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

Department of Biology, Norwegian University of Science and Technology Høgskoleringen 5 7491 TrondheimNorway +47 73 59 61 07
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Avexxin's full profile, request a free trial.

    Avexxin Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Avexxin Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Karolinska InnovationsOtherMinority000 0000000 0000
    Leiv Eiriksson InvestOtherMinority000 0000000 0000
    SarsiaVenture CapitalMinority000 0000000 0000
    SpareBank 1 SMN MarketsOtherMinority000 0000000 0000
    Karolinska Innovations Other
    Leiv Eiriksson Invest Other
    Sarsia Venture Capital
    SpareBank 1 SMN Markets Other

    Avexxin Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Mikael ØrumChief Executive Officer, Chairman & President
    Berit Johansen Ph.DChief Scientific Officer
    Scott WoodwardHead, Business Development
    Anders LjungqvistHead, Regulatory Affairs
    Peter Damsbo MDChief Medical Officer
    Mikael Ørum Chief Executive Officer, Chairman & President
    Berit Johansen Ph.D Chief Scientific Officer
    Scott Woodward Head, Business Development
    Anders Ljungqvist Head, Regulatory Affairs
    Peter Damsbo MD Chief Medical Officer
    Request full access to PitchBook